Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-25 @ 3:31 AM
NCT ID:
NCT04469205
Eligibility Criteria:
Inclusion Criteria:
Any patient active at the time of the diagnosis of breast cancer, treated consecutively at the Institut Curie during the study period, and whose first treatment will be surgery, will be offered participation in the study.
1. Invasive non-metastatic breast cancer, treated first by surgery
2. Age ≥ 18 and ≤ 60 years
3. Active woman at the time of diagnosis
4. Patient with internet access and email address
5. Patient affiliated with a social security scheme, speaking and reading French
6. Signature of informed consent
Exclusion Criteria:
1. In situ breast cancer
2. History of breast cancer
3. Metastatic breast cancer
4. Inflammatory Breast Cancer
5. Woman with a life expectancy \<6 months at the time of diagnosis (in relation to other serious chronic diseases)
6. Persons deprived of liberty or under guardianship
7. Impossibility to submit to the medical follow-up of the test for geographical, social or psychological reasons
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT04469205
Study Brief:
Protocol Section:
NCT04469205